Division of Endocrinology, Children's National Hospital, Washington, District of Columbia, USA.
George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
Horm Res Paediatr. 2021;94(7-8):275-284. doi: 10.1159/000519797. Epub 2021 Sep 24.
The impact of the COVID-19 pandemic on the incidence of pediatric type 1 (T1D) and type 2 diabetes (T2D) and severity of presentation at diagnosis is unclear.
A retrospective comparison of 737 youth diagnosed with T1D and T2D during the initial 12 months of the COVID-19 pandemic and in the preceding 2 years was conducted at a pediatric tertiary care center.
Incident cases of T1D rose from 152 to 158 in the 2 years before the pandemic (3.9% increase) to 182 cases during the pandemic (15.2% increase). The prevalence of diabetic ketoacidosis (DKA) at T1D diagnosis increased over 3 years (41.4%, 51.9%, and 57.7%, p = 0.003); severe DKA increased during the pandemic as compared to the 2 years before (16.8% vs. 28%, p = 0.004). Although there was no difference in the mean hemoglobin A1c (HbA1c) between racial and ethnic groups at T1D diagnosis in the 2-years pre-pandemic (p = 0.31), during the pandemic HbA1c at T1D diagnosis was higher in non-Hispanic Black (NHB) youth (11.3 ± 1.4%, non-Hispanic White 10.5 ± 1.6%, Latinx 10.8 ± 1.5%, p = 0.01). Incident cases of T2D decreased from 54 to 50 cases (7.4% decrease) over the 2-years pre-pandemic and increased 182% during the pandemic (n = 141, 1.45 cases/month, p < 0.001). As compared to the 2-years pre-pandemic, cases increased most among NHB youth (56.7% vs. 76.6%, p = 0.001) and males (40.4% vs. 58.9%, p = 0.005). Cases of DKA (5.8% vs. 23.4%, p < 0.001) and hyperosmolar DKA (0 vs. 9.2%, p = 0.001) increased among youth with T2D during the pandemic.
During the pandemic, the incidence and severity of presentation of T1D increased modestly, while incident cases of T2D increased 182%, with a nearly 6-fold increase in DKA and nearly a 10% incidence of hyperosmolar DKA. NHB youth were disproportionately impacted, raising concern about worsening of pre-existing health disparities during and after the pandemic.
COVID-19 大流行对儿科 1 型(T1D)和 2 型糖尿病(T2D)的发病率和发病时严重程度的影响尚不清楚。
在一家儿科三级保健中心,对大流行期间和前 2 年期间诊断的 737 名青少年进行了 T1D 和 T2D 的回顾性比较。
T1D 的发病例数在前 2 年大流行期间从 152 例增加到 158 例(增加 3.9%),在大流行期间增加到 182 例(增加 15.2%)。T1D 诊断时糖尿病酮症酸中毒(DKA)的患病率在 3 年内增加(41.4%、51.9%和 57.7%,p=0.003);大流行期间的严重 DKA 比前 2 年增加(16.8%比 28%,p=0.004)。虽然在大流行前 2 年 T1D 诊断时不同种族和族裔群体的平均血红蛋白 A1c(HbA1c)之间没有差异(p=0.31),但在大流行期间,非西班牙裔黑人(NHB)青少年的 T1D 诊断时的 HbA1c 更高(11.3±1.4%,非西班牙裔白人 10.5±1.6%,拉丁裔 10.8±1.5%,p=0.01)。T2D 的发病例数在前 2 年大流行期间从 54 例减少到 50 例(减少 7.4%),而在大流行期间增加了 182%(n=141,每月 1.45 例,p<0.001)。与大流行前 2 年相比,NHB 青少年(56.7%比 76.6%,p=0.001)和男性(40.4%比 58.9%,p=0.005)的病例增加最多。T2D 患者的 DKA(5.8%比 23.4%,p<0.001)和高渗性 DKA(0 比 9.2%,p=0.001)病例增加。
在大流行期间,T1D 的发病率和发病严重程度略有增加,而 T2D 的发病例数增加了 182%,DKA 增加了近 6 倍,高渗性 DKA 的发病率增加了近 10%。非西班牙裔黑人青少年受到不成比例的影响,这让人担心大流行期间和之后现有的健康差距会恶化。